NCT00363987View on ClinicalTrials.gov

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

PHASE4CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2009

Conditions
Diabetic Nephropathy
Interventions
DRUG

Ketosteril®

1 tablet Ketosteril/5kgBW/d

OTHER

diabetic diet

Energy 30-35 Kcal/kg BW/d + protein 0.8 g/kg BW/d

Trial Locations (1)

200040

Shanghai Huashan Hospital, Shanghai

Sponsors

Lead Sponsor

Fresenius Kabi
All Listed Sponsors
lead

Fresenius Kabi

INDUSTRY